Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Back to alerts
LAXMIDENTLBSELAXMI DENTAL LIMITED· Healthcare Equipment & SuppliesHighNeutral
Announced Tue, 11 Aug, 2026 · 18:39 IST

Laxmi Dental Q1 FY27 Results: Revenue Up 14%, Consolidated PAT Up 24%

Pat NegativeExceptional ItemResults View source PDFExplain this filing

LAXMIDENTL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-4.2%Reaction day
₹210.20
prior close
₹213.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-4.5% vs market
Medical Equipment & Supplies peers, median of 10sector-0.5%-3.7% vs sector

On the reaction day the stock moved 4.5 pts less than Nifty Microcap 250 and 3.7 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.1
10m
-2.3
15m
-2.0
30m
-1.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-4.2+0.4-4.5-0.5-3.7
Next day
-2.0+0.5-2.5+0.8-2.8
2d
-3.4+0.6-4.0+0.1-3.5
3d
-4.7+0.7-5.4-1.7-3.1
4d
-5.6+1.1-6.8-2.8-2.8
5d
-6.8+0.5-7.3-1.9-4.8
1w
-5.1+1.3-6.4-3.0-2.1
15d
-7.7+0.5-8.2+0.7-8.4
1m
-6.5-0.8-5.7-0.3-6.2
2m
-6.3-0.9-5.3-5.8-0.5
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 10Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Laxmi Dental Q1 FY27: consolidated revenue INR 746.96 million (up 13.9% YoY), PAT INR 103.15 million vs INR 83.30 million (up 23.8%), PBT INR 120.41 million, EPS INR 1.87. Standalone PAT fell to INR 61.71 million vs INR 78.59 million. Board signed LOI for Palghar land (INR 6.21 crore) for new factory, allotted 59,360 ESOP shares. Auditors gave unmodified opinion.

Likely market impact

Mixed quarter. Consolidated revenue and PAT grew on aligners strength; standalone PAT declined. Land LOI signals factory expansion; minor ESOP dilution.